期刊
DRUG DISCOVERY TODAY
卷 18, 期 5-6, 页码 240-249出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2012.10.003
关键词
-
资金
- Marie Keating Foundation PhD Scholarship at Trinity College Dublin
- Science Foundation Ireland [MTCI-SRC/08/B1410]
Cells, grown as monolayers (2D models), are routinely used as initial model systems for evaluating the effectiveness and safety of libraries of molecules with potential as therapeutic drugs. While this initial screening precedes preclinical animal studies before advancing to human clinical trials, cultured cells frequently determine the initial, yet crucial, 'stop/go' decisions on the progressing of the development of a drug. Growing cells as three-dimensional (3D) models more analogous to their existence in vivo, for example, akin to a tumour, and possibly co-cultured with other cells and cellular components that naturally occur in their microenvironment may be more clinically relevant. Here, in the context of anti-cancer drug screening, we review 2D and 3D culture approaches, consider the strengths and relevance of each method.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据